This investigation compares these alternative signaling pathways, specifically key proteins of the Wnt and mTOR pathways, in model NSCLC cell lines positive or negative for EGFR-activating mutation T790M. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.